MR 7700 Multinuclear Application Clinical Study

Sponsor
Philips Clinical & Medical Affairs Global
Study ID
NCT07368049
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • MR Scanning with Phosphorus nucleus + Sodium nucleus — DEVICE
    Using the Magnetic Resonance Equipment to perform phosphorus nucleus (31P) and sodium nucleus (23Na) scanning

Study Details

The purpose of this clinical study is to perform phosphorus nucleus (31P) and sodium nucleus (23Na) imaging of the liver in patients with primary hepatocellular carcinoma (HCC) and healthy volunteers using the MR 7700 Magnetic Resonance Equipment, in order to explore the manifestations of multinuclear imaging in HCC patients and healthy volunteers.

Key Dates

First listed
Jan 26, 2026
Start date
Jan 5, 2026
Status verified
Jan 2026
Primary completion
Jun 30, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: HCC patients
    HCC patients
  • Placebo Comparator: Healthy volunteers
    Healthy volunteers

Primary Outcome Measure

Ratio of metabolites （PME/PDE） [ Time Frame: 14 days (anticipated)] after finishing 31P-MRS scanning ]

Central Contacts

Find similar trials

Nationwide
Liver cancer trialsOncology trialsGI oncology trialsHepatology trials

Related Studies